384 related articles for article (PubMed ID: 31173991)
21. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
[TBL] [Abstract][Full Text] [Related]
22. Fecal microbiota transplantation for the treatment of Clostridium difficile infection.
Rao K; Safdar N
J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412
[TBL] [Abstract][Full Text] [Related]
23. An overview of fecal microbiota transplantation: techniques, indications, and outcomes.
Brandt LJ; Aroniadis OC
Gastrointest Endosc; 2013 Aug; 78(2):240-9. PubMed ID: 23642791
[No Abstract] [Full Text] [Related]
24. Faecal Microbiota Transplantation as Emerging Treatment in European Countries.
Maida M; Mcilroy J; Ianiro G; Cammarota G
Adv Exp Med Biol; 2018; 1050():177-195. PubMed ID: 29383670
[TBL] [Abstract][Full Text] [Related]
25. Fecal microbiota transplantation for irritable bowel syndrome: Current evidence and perspectives.
Dai C; Huang YH; Jiang M
World J Gastroenterol; 2024 Apr; 30(16):2179-2183. PubMed ID: 38690018
[TBL] [Abstract][Full Text] [Related]
26. Consensus report: faecal microbiota transfer - clinical applications and procedures.
König J; Siebenhaar A; Högenauer C; Arkkila P; Nieuwdorp M; Norén T; Ponsioen CY; Rosien U; Rossen NG; Satokari R; Stallmach A; de Vos W; Keller J; Brummer RJ
Aliment Pharmacol Ther; 2017 Jan; 45(2):222-239. PubMed ID: 27891639
[TBL] [Abstract][Full Text] [Related]
27. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
[TBL] [Abstract][Full Text] [Related]
28. Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases.
Núñez F P; Quera R; Bay C; Thomson P
Gastroenterol Hepatol; 2022 Mar; 45(3):223-230. PubMed ID: 34118321
[TBL] [Abstract][Full Text] [Related]
29. Fecal microbiota transplantation in gastrointestinal diseases: what practicing physicians should know.
Borody TJ; Connelly N; Mitchell SW
Pol Arch Med Wewn; 2015; 125(11):852-8. PubMed ID: 26397161
[TBL] [Abstract][Full Text] [Related]
30. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
[TBL] [Abstract][Full Text] [Related]
31. Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.
Holleran G; Scaldaferri F; Ianiro G; Lopetuso L; Mc Namara D; Mele MC; Gasbarrini A; Cammarota G
Drugs Today (Barc); 2018 Feb; 54(2):123-136. PubMed ID: 29637938
[TBL] [Abstract][Full Text] [Related]
32. Clinical practice guidelines for Clostridioides (Clostridium) difficile infection and fecal microbiota transplant protocol - recommendations of the Polish Society od Epidemiology and Infectious Diseases.
Piekarska A; Panasiuk A; Stępień PM
Przegl Epidemiol; 2020; 74(1):69-87. PubMed ID: 32500988
[TBL] [Abstract][Full Text] [Related]
33. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'.
Tan X; Johnson S
Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233
[TBL] [Abstract][Full Text] [Related]
34. Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)?
Pinn DM; Aroniadis OC; Brandt LJ
Neurogastroenterol Motil; 2015 Jan; 27(1):19-29. PubMed ID: 25424663
[TBL] [Abstract][Full Text] [Related]
35. Current applications of fecal microbiota transplantation in intestinal disorders.
Hsu WH; Wang JY; Kuo CH
Kaohsiung J Med Sci; 2019 Jun; 35(6):327-331. PubMed ID: 31017741
[TBL] [Abstract][Full Text] [Related]
36. Microbiota transplantation: concept, methodology and strategy for its modernization.
Zhang F; Cui B; He X; Nie Y; Wu K; Fan D;
Protein Cell; 2018 May; 9(5):462-473. PubMed ID: 29691757
[TBL] [Abstract][Full Text] [Related]
37. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.
Weingarden AR; Vaughn BP
Gut Microbes; 2017 May; 8(3):238-252. PubMed ID: 28609251
[TBL] [Abstract][Full Text] [Related]
38. Fecal microbial transplantation: an update.
Bouri S; Hart A
Curr Opin Clin Nutr Metab Care; 2018 Sep; 21(5):405-410. PubMed ID: 29939968
[TBL] [Abstract][Full Text] [Related]
39. Current perspectives on fecal microbiota transplantation in inflammatory bowel disease.
Singh A; Midha V; Chauhan NS; Sood A
Indian J Gastroenterol; 2024 Feb; 43(1):129-144. PubMed ID: 38334893
[TBL] [Abstract][Full Text] [Related]
40. Sex-Discordant Fecal Microbiota Transplantation for Clostridioides difficile May Increase Risk of Postinfection Irritable Bowel Syndrome.
Sehgal K; Yadav D; Saha S; Mara K; Grover M; Khanna S
Gastroenterology; 2024 Apr; 166(4):704-706.e2. PubMed ID: 38056511
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
